Cargando…
Functional imaging biomarkers for assessing response to treatment in liver and lung metastases
Management of patients with metastatic cancer and development of new treatments rely on imaging to provide non-invasive biomarkers of tumour response and progression. The widely used size-based criteria have increasingly become inadequate where early measures of response are required to avoid toxici...
Autores principales: | Bernardin, Livia, O’Flynn, Elizabeth A.M., deSouza, Nandita M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Med
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864224/ https://www.ncbi.nlm.nih.gov/pubmed/24334562 http://dx.doi.org/10.1102/1470-7330.2013.0047 |
Ejemplares similares
-
Functional magnetic resonance: biomarkers of response in breast cancer
por: O'Flynn, Elizabeth AM, et al.
Publicado: (2011) -
Correction: Functional magnetic resonance: biomarkers of response in breast cancer
por: O'Flynn, Elizabeth AM, et al.
Publicado: (2011) -
Diffusion-weighted magnetic resonance imaging and its application to cancer
por: Charles-Edwards, Elizabeth M, et al.
Publicado: (2006) -
The role of imaging in the diagnosis of primary prostate cancer
por: Harvey, Hugh, et al.
Publicado: (2016) -
MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423)
por: Jackson, Alan, et al.
Publicado: (2023)